1st Circ. To Review Crucial Issue In Teva, Regeneron Cases

By Yeji Jesse Lee · November 17, 2023, 9:15 PM EST

The First Circuit on Friday granted Teva Pharmaceutical's request to settle how rigorous the causation standard should be in federal False Claims Act kickback cases, a legal issue that has previously...

To view the full article, register now.

Documents

Case Information

Case Title

US v. Teva Pharmaceuticals USA, Inc., et al

Case Number

23-8028

Court

Appellate - 1st Circuit

Nature of Suit

Date Filed

August 23, 2023